🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Xigduo XR

Found 23 matching trials

A Clinical Study in Healthy Adults to See How the Body Processes and How Safe a Tablet That Combines Gemigliptin, Dapagliflozin, and Metformin is, Compared With Taking Zemiglo and Xigduo XR Together While Fasting.

PHASE1

Bioequivalence study for the fixed-dose combination of Gemigliptin/Dapaglif...

Status

Completed

Location

Jeonbuk National University Hospital

Start Date

2026-01-09

Trial ID

NCT07399470

Treatments Being Tested

Test drug: Fixed-dose combination of gemigliptin/dapagliflozin/metformin 50/10/1000 mg Reference drug: Gemigliptin (Zemiglo) 50mg, Dapagliflozin/metformin (Xigduo XR) 10/1000 mg

Evaluation of SGLT2-i Effectivness and Safety in Elderly Type 2 Diabetes Patients

N/A

The aim of the study is to evaluate the benefits, documented in experimenta...

Status

Unknown

Location

ASST FBF Sacco

Start Date

2022-09

Trial ID

NCT05477017

Treatments Being Tested

SGLT2 inhibitor

Effectiveness & Tolerability of Novel, Initial Triple Combination Therapy vs Conventional Therapy in Type 2 Diabetes

PHASE3

In this study, the investigators will assess the efficacy and tolerability ...

Status

Unknown

Location

Korea University Anam Hospital

Start Date

2016-12

Trial ID

NCT02946632

Treatments Being Tested

triple combination therapy Stepwise add-on therapy

of Sodium Glucose Cotransporter-2 Inhibitors on Metabolic, Hormonal and Clinical Parameters in PCO

PHASE3

The aim of this study is to compare the hormonal, metabolic and clinical ef...

Status

Unknown

Location

Beni-suef university

Start Date

2022-01-15

Trial ID

NCT05601336

Treatments Being Tested

Dapagliflozin 5 MG Metformin Hydrochloride 1000 MG Dapagliflozin/Metformin

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HCP1801 in Healthy Subjects

PHASE1

An open-label, randomized, single-dose crossover study to evaluate the phar...

Status

Completed

Location

Kyungpook National University Hospital

Start Date

2019-02-01

Trial ID

NCT03826641

Treatments Being Tested

HCP1805 HCP1801

An Open-label, Randomized, Crossover Study of Comparative Pharmacokinetics and Bioequivalence of Dapagliflozin + Metformin, 10 mg + 1000 mg Versus the Combined Use of Forxiga™, 10 mg and Two Glucophage® Long, ER Tablets, 500 mg Co-administered to Healthy Volunteers Under Standard Fed Conditions

PHASE1

The aim of this study is to demonstrate bioequivalence of fixed dose combin...

Status

Completed

Location

Research Site

Start Date

2016-03-30

Trial ID

NCT02722239

Treatments Being Tested

Xigduo XR Metformin ER (Glucophage® long)Dapagliflozin (Forxiga)

A Study to Assess the Bioequivalence of Dapagliflozin/Metformin XR Fixed-dose Combination Tablets in Healthy Subjects

PHASE1

This is a bioequivalence study to compare 2 fixed-dose combination tablets ...

Status

Completed

Location

Research Site

Start Date

2015-12-21

Trial ID

NCT02637037

Treatments Being Tested

dapagliflozin/metformin XR 5/500 mg test drug (Mount Vernon)dapagliflozin/metformin XR 5/500 mg reference drug (Humacao)dapagliflozin/metformin XR 10/1000 mg test drug (Mount Vernon)dapagliflozin/metformin XR 10/1000 mg reference drug (Humacao)

Effects of Dapagliflozin and Metformin on Vascular Function in Newly-Diagnosed Treatment-Naive Type 2 Diabetes

PHASE4

Trial Design: This is a 12 week randomised controlled open label trial comp...

Status

Unknown

Location

Tan Tock Seng Hospital

Start Date

2019-04-01

Trial ID

NCT05440591

Treatments Being Tested

Dapagliflozin MetFORMIN 500 Mg Oral Tablet Dapagliflozin / metFORMIN Pill

Dapagliflozin and Metformin,Alone and in Combination, in Overweight/Obese Prior GDM Women

PHASE3

Women with a history of gestational diabetes (GDM) are at substantially inc...

Status

Completed

Location

Woman's Hospital

Start Date

2015-09-22

Trial ID

NCT02338193

Treatments Being Tested

DAPA/MET XR DAPA MET XR

A Study to Evaluate the Food Effect on Drug Availability, Pharmacokinetic (PK) Properties, Safety and Tolerability of Two Different Dose Combination Therapy of Saxagliptin/Dapagliflozin/Metformin Extended-release (XR) Against Individual Component Co-administration.

PHASE1

A Study to Assess the Fed-state Bioequivalence of a Triple Fixed-Combinatio...

Status

Completed

Location

Research Site

Start Date

2017-05-29

Trial ID

NCT03169959

Treatments Being Tested

2.5 mg Saxagliptin tablet 5 mg dapagliflozin / 1000 mg metformin XR tablet Triple FCDP - 2.5 mg saxagliptin / 5 mg dapagliflozin / 1000 mg metformin XR 5 mg saxagliptin 10 mg dapagliflozin / 1000 mg metformin XR tablet Triple FCDP - 5 mg saxagliptin / 10 mg dapagliflozin / 1000 mg metformin XR

Previous Next